article thumbnail

Diagnosing Pediatric Crohn Disease With Radiomic and Clinical Data

Imaging Technology

milla1cf Wed, 08/02/2023 - 19:58 August 2, 2023 — An accepted manuscript published in the American Journal of Roentgenology (AJR) found that deploying a radiomic-based model with T2-weighted MRI data could increase diagnostic accuracy for pediatric Crohn disease (CD). Dillman et al.’s and accuracy of 89.6%. and accuracy of 89.6%.

article thumbnail

Thirona Announce Partnerships to Enhance AI-based Lung Image Analysis

Imaging Technology

Food and Drug Administration (FDA) approval for its latest update of its AI-based clinical software LungQ (v3.0.0). The announcement noted that Blackford provides healthcare professionals access to an extensive portfolio of more than 130 AI solutions designed to augment clinical accuracy and drive efficiency and improve patient outcomes.

Imaging 66
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Clinical Conundrums: Do We Need to Order a CT for Every Patient with Renal Colic?

REBEL EM

Clinical Scenario: A 35-year-old man with no PMH presents with left flank pain, hematuria and history of kidney stones. In a young patient who has a clear clinical diagnosis, there is no required imaging. ” The Journal of Urology 199.4S (2018): e683-e684. POCUS can help guide imaging decisions. 2011; 18(7):699-707.

Clinic 60
article thumbnail

Terran Biosciences Receives FDA Clearance for NM-101, the Industry’s First Software for the analysis of Neuromelanin-sensitive MRI

Imaging Technology

We believe this technology could become very important in the clinical workflow of patients with neurological and psychiatric disorders.” While neuromelanin was first described in the 19 th century, researchers have elucidated its possible role as a biomarker for neurological disorders such as Parkinson’s disease in the last two decades.

article thumbnail

LI-RADS shows low NPV in per-patient liver tumor assessment

AuntMinnie

However, the researchers noted that the emphasis on specificity can lead to disease under-staging. Using this, tumors were categorized into the following: viable (LI-RADS 4, 5, or treatment response), equivocal (LI-RADS 3 or treatment response), and no viable disease (only LI-RADS treatment response).

Disease 114
article thumbnail

Blue Earth Diagnostics Announces Addition of POSLUMA (Flotufolastat F 18) Injection to NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer

Imaging Technology

We believe it further validates the clinical utility of POSLUMA in patients with newly diagnosed or recurrent prostate cancer, and can help expand patient access. FDA, as well as on the Phase 3 clinical trial results published recently in the Journal of Urology and European Urology. Chief Executive Officer of the Company. “We

Clinic 84
article thumbnail

ECR: What makes small ovarian lesions light up like a lightbulb?

AuntMinnie

Max Lahaye, MD, of the Netherlands Cancer Institute in Amsterdam presents findings on the clinical impact of dedicated MR staging of ovarian cancer patients during ECR 2024. that every visible disease has to be removed surgically," Lahaye said. We as radiologists have a problem in depicting disease on CT, peritoneal disease.

MRI 104